Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Regionshospitalet Viborg, Skive
• Treatments: Buserelin; Chorionic Gonadotropin

Criteria

Inclusion Criteria:

• Patient complying with the conditions for IVF or ICSI treatment

• Female age over 20 years and under 40 years

• Normal regular cycle and patients with oligomenorrhea

• BMI > 18 and < 35

• each patient contributes with one cycle only

Exclusion Criteria:

• Significant disturbances in the woman (diabetes, epilepsy, liver/renal/heart disease, metabolic disorder)

• Patients with > 25 follicles on the day of triggering ovulation